Results for tag: "Kabuki Syndrome Drug"

Kabuki Syndrome Drug is a type of Central Nervous System (CNS) drug used to treat the rare genetic disorder Kabuki Syndrome. This disorder is characterized by intellectual disability, skeletal abnormalities, and facial dysmorphism. The Kabuki Syndrome Drug market is a relatively small market, with only a few drugs approved for the treatment of this disorder. These drugs are typically used in combination with other therapies, such as physical and occupational therapy, to improve the patient's quality of life. The Kabuki Syndrome Drug market is highly competitive, with several companies vying for market share. Some of the major players in this market include AbbVie, Pfizer, Novartis, and Sanofi. Other companies, such as Shire, Merck, and Takeda, are also active in this market. Show Less Read more